Clinical Trial Update: A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial compares apatinib to docetaxel in patients with advanced gastric cancer, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Gastric Carcinoma | Phase 2, Phase 3 | Status: UNKNOWN